Written Question·Department of Health and Social Care·UIN 108762
Rare Diseases: Medical Treatments
Tabled: 27 January 2026
Answered: 3 February 2026
Question
Anneliese Dodds
Labour (Co-op) — Oxford East
To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential merits of increasing NICE's cost-effectiveness thresholds used to evaluate Highly Specialised Technologies for rare diseases.
Answer
Dr Zubir AhmedThere are currently no plans to increase the cost‑effectiveness threshold for the highly specialised technologies (HST) programme. The HST programme already operates at a much higher threshold than standard National Institute for Health and Care Excellenc...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 108762) →